Related Experiment Video
Updated: Oct 7, 2025

An In Vitro Model for the Study of Cellular Pathophysiology in Globoid Cell Leukodystrophy
Published on: October 21, 2014
Prion-like α-synuclein pathology in the brain of infants with Krabbe disease
Christopher Hatton1,2, Simona S Ghanem3, David J Koss2
1Wellcome Centre for Mitochondrial Research, Claremont Road, Newcastle NE2 4AA, UK.
Insights
Krabbe disease, a neurodegenerative disorder, shows prion-like alpha-synuclein accumulation in infants, similar to Lewy body disease. This suggests alpha-synuclein pathology arises from metabolic pathway alterations, not just aging.
Area of Science:
- Neuroscience
- Biochemistry
- Genetics
Background:
- Krabbe disease is an infantile neurodegenerative disorder caused by GALC gene variants, leading to toxic psychosine accumulation.
- GALC variants are also linked to Lewy body diseases, characterized by alpha-synuclein aggregation.
Purpose of the Study:
- To investigate pathological similarities of alpha-synuclein in Krabbe disease brain tissue compared to Lewy body disease.
- To determine if alpha-synuclein in Krabbe disease exhibits disease-associated pathogenic properties.
Main Methods:
- Observational post-mortem study of Krabbe disease brain tissue (n=4) and infant controls (n=4).
- Evaluation of alpha-synuclein seeding capacity using real-time quaking-induced conversion (RT-QuIC) assay on available frozen tissue.
Main Results:
- Widespread alpha-synuclein accumulations were identified in Krabbe disease infant brains.
- Krabbe disease-derived alpha-synuclein demonstrated prion-like aggregation into fibrils, similar to Lewy body disease.
Conclusions:
- This is the first report of prion-like alpha-synuclein in infant brains.
- Alpha-synuclein pathology may result from altered biological pathways like sphingolipid metabolism, challenging the age-associated view.
- Findings impact understanding of Lewy body formation mechanisms.
Abstract:
Krabbe disease is an infantile neurodegenerative disorder resulting from pathogenic variants in the GALC gene that causes accumulation of the toxic sphingolipid psychosine. GALC variants are also associated with Lewy body diseases, an umbrella term for age-associated neurodegenerative diseases in which the protein α-synuclein aggregates into Lewy bodies. To explore whether α-synuclein in Krabbe disease has pathological similarities to that in Lewy body disease, we performed an observational post-mortem study of Krabbe disease brain tissue (n = 4) compared to infant controls (n = 4) and identified widespread accumulations of α-synuclein. To determine whether α-synuclein in Krabbe disease brain displayed disease-associated pathogenic properties we evaluated its seeding capacity using the real-time quaking-induced conversion assay in two cases for which frozen tissue was available and strikingly identified aggregation into fibrils similar to those observed in Lewy body disease, confirming the prion-like capacity of Krabbe disease-derived α-synuclein. These observations constitute the first report of prion-like α-synuclein in the brain tissue of infants and challenge the putative view that α-synuclein pathology is merely an age-associated phenomenon, instead suggesting it results from alterations to biological pathways, such as sphingolipid metabolism. Our findings have important implications for understanding the mechanisms underlying Lewy body formation in Lewy body disease.
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Neural Regulation

